91 results
Page 3 of 5
8-K
EX-99.1
b5x4uztrhoaywk2 wwic
25 Mar 21
Viridian Therapeutics Reports 2020 Financial Results and Provides Corporate Updates
4:06pm
8-K
EX-10.1
tzh82i3b4s mpgmelqy
20 Jan 21
Departure of Directors or Certain Officers
8:01am
424B5
7t91v1hhe5cpnc2zogo
11 Dec 20
Prospectus supplement for primary offering
4:46pm
PRER14A
26tjak
8 Dec 20
Preliminary revised proxy
4:11pm
8-K
EX-99.2
fub6kwttlfdao tv
28 Oct 20
Acquisition includes clinical stage anti-IGF-1R monoclonal antibody, VRDN-001, intended for Company plans to use private placement financing proceeds of $91 million to advance multiple
9:28am
8-K
EX-99.1
i6vy51gh
17 Sep 20
Lee Rauch appointed President and CEO, following resignation by William Marshall
5:24pm
8-K
EX-10.3
5m79my
17 Sep 20
Lee Rauch appointed President and CEO, following resignation by William Marshall
5:24pm
8-K
EX-10.1
3znm 7nt2h
19 Jun 20
Departure of Directors or Certain Officers
4:16pm
8-K
3mbfmmm9
19 Feb 20
Departure of Directors or Certain Officers
4:15pm
424B5
rd61s
7 Feb 20
Prospectus supplement for primary offering
5:03pm
424B5
gztu3r5h 3m1ybuphm0j
6 Feb 20
Prospectus supplement for primary offering
5:29pm
424B5
dd12gycupd
12 Dec 19
Prospectus supplement for primary offering
4:29pm